Mostrar el registro sencillo del ítem
dc.contributor.author
Bertolesix, Gabriel Esteban
dc.contributor.author
Lauría de Cidre, Lilia
dc.contributor.author
Sacerdote de Lustig, Eugenia
dc.contributor.author
Eiján, Ana María
dc.date.available
2021-01-13T21:44:36Z
dc.date.issued
1995-04-14
dc.identifier.citation
Bertolesix, Gabriel Esteban; Lauría de Cidre, Lilia; Sacerdote de Lustig, Eugenia; Eiján, Ana María; Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition; Elsevier; Cancer Letters; 90; 2; 14-4-1995; 123-131
dc.identifier.issn
0304-3835
dc.identifier.uri
http://hdl.handle.net/11336/122696
dc.description.abstract
Binding of heparin to primary cultured cells of two murine mammary adenocarcinomas with low (M3) and high (MM3) lung, metastatic capacity was determined. Heparin binding was rapid, specific and saturable. MM3 cells grown for 24 h in fetal calf serum (FCS)-free medium exhibited a higher number of binding sites for 3H-heparin [(11 ± 1) × 105 sites per cell] than M3 cells [(6.9 ± 0.6) × 105 sites per cell]. However, when M3 cells were grown in the presence of 2% FCS, they showed less heparin binding sites [(3.5 ± 0.4) × 105 sites per cell]. In contrast, dissociation constants were very similar for MM3 and M3 cells grown with or without FCS (Kd = 2−4 × 10−9M). Furthermore, heparin inhibited MM3 and M3 cell growth both in the absence or presence of FCS. Competition studies showed that chemically modified heparins lacking antiproliferative effect (O-desulfated; O/N-desulfated N-acetylated and N-desulfated heparins) were not able to inhibit 3H-heparin binding. N-desulfated N-acetylated heparin, which had partial antiproliferative effect, partially inhibited 3H-heparin binding, while heparin with a high antiproliferative activity inhibited more than 90% 3H-heparin binding. The antiproliferative effect of heparin and chemically modified heparins seems to be related to their binding ability to the cell membrane.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
RECEPTOR
dc.subject
GROWTH INHIBITION
dc.subject
TUMOR
dc.subject
METASTASIS
dc.subject
HEPARIN
dc.subject
SACERDOTE INVESTIGADORA
dc.subject
PUBLICACIONES
dc.subject.classification
Oncología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
dc.journal.volume
90
dc.journal.number
2
dc.journal.pagination
123-131
dc.journal.pais
Países Bajos
dc.journal.ciudad
Ámsterdam
dc.description.fil
Fil: Bertolesix, Gabriel Esteban. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
dc.description.fil
Fil: Lauría de Cidre, Lilia. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Biodiversidad y Biología Experimental. Laboratorio de Histología Animal; Argentina
dc.description.fil
Fil: Sacerdote de Lustig, Eugenia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Eiján, Ana María. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
dc.journal.title
Cancer Letters
dc.provenance
Otro
dc.format.espacioDeColor
EscalaGris
dc.format.compresion
No especifica
dc.description.nivelDescripcion
Unidad documental simple
dc.type.subtype
Artículo científico
dc.type
info:ar-repo/semantics/artículo
Archivos asociados